Navigation Links
Silence Therapeutics Announces Issuance of Japanese Patent for Screening Therapeutics Against Key Pathway Associated with Cancer and Other Diseases
Date:9/16/2011

LONDON, September 16, 2011 /PRNewswire/ --


Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading RNA interference (RNAi) therapeutics company, announces the issuance of patent 4810095 entitled "Use of Protein Kinase N beta" by the Japanese Patent Office. The issued patent covers certain methods for screening a therapeutic agent for the treatment and/or prevention of any disease that involves elevated activity within the PI3-kinase pathway. More specifically, this new intellectual property covers the use of protein kinase N 3 ("PKN3") for screening of therapeutic agents, thus preventing others from using PKN3 for screening purposes. This new patent is broadly directed to various classes of therapeutic agents with the potential to impact the PI3-kinase pathway including short interfering RNA (siRNA) molecules, antibodies and small molecules, among others.  

PKN3 is a protein kinase C-related molecule, involved in the PI3-kinase pathway that is believed to play an important role in the growth of cancer cells, as well as metastasis formation. Silence has built a significant research program around PKN3 and the company's lead clinical compound, Atu027, is an RNAi therapeutic that targets PKN3 for the treatment of advanced solid tumors.  

"We are excited about consolidating our broad patent portfolio in Japan, especially as it pertains to our high-value PKN3 program," said Dr Klaus Giese, chief scientific officer of Silence Therapeutics. "This patent positions Silence as the exclusive gatekeeper for any project focused on developing therapeutics targeting PKN3, and as interest in this important oncology target continues to grow rapidly, we expect the value of this intellectual property position will also increase significantly."

Silence Therapeutics is proactively building and strengthening its global, diverse and competitive intellectual property portfolio. This provides the Company and po
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
2. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
3. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
4. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
5. Silence Therapeutics Provides Year-end Update
6. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
7. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
8. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Silence Therapeutics Announces Board Changes
11. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 /CNW/ - The ... Inc. (GSK) is voluntarily recalling one lot (lot 710535) of ... two glass pieces had been found in one bottle of ... affected at this time. Clavulin-400 is an oral ... older to treat various bacterial infections. Clavulin-400 comes as a ...
(Date:4/17/2015)... Contego Medical, the first and only ... for angioplasty balloon and stent delivery catheters, announces ... financing round led by Hatteras Venture Partners, an ... medical devices, biopharmaceuticals, diagnostics and related opportunities in ... Partners, Lookout Capital and Medical Mutual. ...
(Date:4/17/2015)... HILL, N.C. , April 17, 2015  Regulatory ... the newly released bipartisan discussion draft called "21 st ... document is planned to be taken up by Congress ... how pharmaceutical and medical device products are developed and ... For that reason, many companies have begun to consider ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 321st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2
... Data from 1,237 Facilities Demonstrates,Public Health ... States,Across Healthcare Facility Units, SAN JOSE, ... The,Association for Professionals in Infection Control ... from a nationwide study of,1,237 U.S. ...
... Is Commonly Seen In,Insulin Therapy , CHICAGO, June ... a new study that further demonstrated the safety ... Patients with Type 2 diabetes were able ... improvements in blood,sugar, comparable to dosing adjusted by ...
Cached Medicine Technology:Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates 2Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5
(Date:4/18/2015)... April 18, 2015 French physician and ... food choices when he uttered, “Tell me what you ... Using food to cope with stress or sadness has ... Queendom.com indicates otherwise. Data collected from their ... victim to emotional eating, but for different reasons. , ...
(Date:4/17/2015)... April 17, 2015 Riviera Magazine ... Kevin Sadati of the Gallery of Cosmetic Surgery ... top beauty experts. The publication focused on his ... stem cell fat grafting, eyelid surgery, laser resurfacing and ... plastic surgery has resulted in thousands of satisfied ...
(Date:4/17/2015)... In Defense of Christians (IDC) Executive Director Kirsten ... 15th, the European Parliament joined its voice with other ... Genocide, “paying tribute, on the eve of the centenary, ... victims who perished in the Ottoman Empire.” In ... timely and needed recognition of a tragic episode in ...
(Date:4/17/2015)... At the end of February 2015, Choices Recovery ... the Oscars” in the Stardust Penthouse on the rooftop ... Los Angeles skyline. These events honoring the 2015 Oscar ... producer of sustainable product placement in TV and film. ... of eco-friendly and socially conscious products and services, the ...
(Date:4/17/2015)... April 17, 2015 Scientists from ... multicenter team of U.S. and Venezuelan researchers, have ... in humans among an isolated tribe of Yanomami ... Bacterial diversity in the Yanomami, previously unexposed to ... nearly double that of people living in industrialized ...
Breaking Medicine News(10 mins):Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 3
... can reduce infant mortality rates; the Centre has asked the ... the lines of the initiative for polio immunization. ,Breast ... cent. It is not only the best food for the ... throughout life, Secretary Women and Child Development Reva Nayyar said. ...
... leafy vegetables such as kale, spinach and collard greens ... ,These vegetables are known to contain a variety of ... lutein, vitamins C and E, flavonoids, folic acid, and ... ,Researchers studied over 1,000 adults living in Australia over ...
... of Disease in Childhood says ‘Low birthweight babies and ... hyperactive and with low attention spans’ according to a ... behaviour characterise the syndrome known as hyperkinetic disorder, or ... common mental disorders diagnosed among children, say the authors. ...
... caffeine makes us more likely to say ‘yes’ to ... //of stimulants increases people's willingness to be ... how they viewed voluntary euthanasia and abortion. ... laced with the caffeine equivalent of two cups of ...
... between 34 and 36 weeks had about 70% more chances ... ,Babies born at even less than 34 //weeks had three ... Danish Researchers is based on findings of 30,000 children ... increased occurrence of ADHD among children with a low ...
... habit of enjoying the sun in its totality, without the ... UK skin cancer figures are close to 65,400as per ... contract a deadly malignant melanoma which results in 1600 deaths ... cosmetic doctor Simon Connolly of Edinburgh's Mulberry House, 'Its vital ...
Cached Medicine News:Health News:Skin Cancer Risk Reduced by Taking Green Leafy Vegetables 2Health News:Premature Birth Could Lead to ADHD 2
Colloidal Gold Sol, 40 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 30 nm 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: